Next 10 |
home / stock / cdtx / cdtx articles
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., May 14, 2024. Rosen Law Firm, a global investor rights law firm, announces an i...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&...
Shares of Teradyne, Inc. (NASDAQ:TER) rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and iss...
- $240 million private placement financing led by RA Capital Management with significant participation by Bain Capital Life Sciences as well as BV...
Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical develo...
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financia...
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion ...
Cidara Therapeutics Inc (NASDAQ:CDTX) shares are trading lower by 24.4% to $0.52 Monday afternoon. The company announced a 1-for-20 reverse stock s...
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
2024-07-16 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients ...